Freeline Announces 2022 Corporate Priorities and Guidance

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Congress
Freeline Appoints Paul Schneider as Chief Financial Officer
Freeline to Present Data at the 2021 Virtual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) and the 17th Annual WORLDSymposium™ 2021
Freeline Announces FDA Clearance of Investigational New Drug Application for FLT201 for Gaucher Disease Type 1
Freeline Announces Closing of Sale of Its CMC-Focused German Subsidiary
Freeline announces supply agreement for haemophilia B program
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels